Filing Details
- Accession Number:
- 0000899243-19-030063
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-12-26 17:30:37
- Reporting Period:
- 2019-12-20
- Accepted Time:
- 2019-12-26 17:30:37
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1750019 | Tcr2 Therapeutics Inc. | TCRR | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1362054 | Patrick Baeuerle | Tcr2 Therapeutics Inc. 100 Binney Street Cambridge MA 02142 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2019-12-20 | 32,022 | $15.16 | 435,693 | No | 4 | S | Indirect | By APAK Solutions GmbH |
| Common Stock | Disposition | 2019-12-23 | 84,907 | $15.44 | 350,786 | No | 4 | S | Indirect | By APAK Solutions GmbH |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | By APAK Solutions GmbH |
| No | 4 | S | Indirect | By APAK Solutions GmbH |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.
- $15.16 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.00 to $15.87, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- The reported securities are owned directly by APAK Solutions GmbH. The Reporting Person is managing director of APAK Solutions GmbH. The Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his pecuniary interest therein.
- $15.44 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.01 to $16.29, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Billionaire Hedge Funds
